FDA Warning Letter — Jagsonpal Pharmaceuticals Ltd.
The FDA took a Warning Letter action against Jagsonpal Pharmaceuticals Ltd. on February 5, 2025 (Alwar, India). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Jagsonpal Pharmaceuticals Ltd.
- Date
- February 5, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Center
- CDER
- Location
- Alwar (India)